Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15757 articles
Metabolic abnormalities and survival among patients with non-metastatic breast cancer
Patients with low HDL-C (≤ 45 vs. > 45 mg/dL) had higher breast cancer-specific mortality.
»
12/29/22
Immune checkpoint blockade PD-1 therapy for primary liver cancer: incidence and influencing factors of thyroid dysfunction
Patients with PLC had high incidence of TD after receiving PD-1 treatment.
»
12/29/22
Targeting hyaluronic acid synthase-3 (HAS3) for the treatment of advanced renal cell carcinoma
RCC cells showed increased HAS3 expression.
»
12/29/22
Interactions of melatonin with various signaling pathways: implications for cancer therapy
Role of melatonin in regulating multiple signaling pathways.
»
12/29/22
Merkel cell carcinoma: a forty-year experience at the Peter MacCallum Cancer Centre
Estimated 5-year OS and DFS 46% and 34% respectively.
»
01/07/23
Gene signature and prognostic value of ubiquitination-related genes in endometrial cancer
New endometrial cancer prognostic model with 5 newly identified genes.
»
01/07/23
Molecular features and race-associated outcomes of SPOP-mutant metastatic castration-resistant prostate cancer.
SPOP-mut associated with longer PSA-PFS in mCRPC.
»
11/28/22
Survival Impact of Postoperative Skeletal Muscle Loss in Gastric Cancer Patients Who Underwent Gastrectomy.
Postoperative severe SML significantly associated with presence of comorbidities, higher tumor stage.
»
10/28/22
Differences in Toxicity Between Ashkenazi and Sephardic Jews With Colon Cancer Treated With Adjuvant Chemotherapy: A Prospective Study.
Sephardic patients receiving oxaliplatin-containing regimens at increased risk for neurotoxicity.
»
11/02/22
Sotorasib in KRAS p.G12C-Mutated Advanced Pancreatic Cancer.
Sotorasib showed anticancer activity and acceptable safety profile in patients with KRAS p.G12C mutation.
»
12/23/22
< Prev
Next >